REFERENCES
- Mannino D M, Homa D M, Akinbami L J, Ford E S, Redd S C. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR, Surveill Summ 2002; 51(6):1–16.
- American Thoracic Society/European Respiratory SocietyGuidelines Update, 2003; Available atwww.thoracic.org. Accessed November 2003.
- Anthonisen N R, Connett J E, Murray R P. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002; 166(5):675–679. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Norman G R, Sloan J A, Wyrwich K W. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41(5):582–592. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Miller G A. The magic number seven plus or minus two, some limits on our capacity to process information. Psychol Rev 1956; 63:81–97. [PUBMED], [INFOTRIEVE]
- Rennard S I, Calverley P. Rescue! Therapy and the paradox of the Barcalounger. Eur Respir J 2003; 21(6):916–917. [PUBMED], [INFOTRIEVE]
- Rennard S, Decramer M, Calverley P M, Pride N B, Soriano J B, Vermeire P A, Vestbo J. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002; 20(4):799–805. [PUBMED], [INFOTRIEVE], [CROSSREF]
- O'Donnell D E, Revill S M, Webb K A. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164(5):770–777. [PUBMED], [INFOTRIEVE], [CSA]
- Seemungal T A, Donaldson G C, Bhowmik A, Jeffries D J, Wedzicha J A. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161(5):1608–1613. [PUBMED], [INFOTRIEVE], [CSA]
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2003. Available at: www.goldcopd.com. Accessed November 2003.
- Fletcher C, Peto R, Tinker C, Speizer F E. The Natural History of Chronic Bronchitis and Emphysema. New York: Oxford University Press, 1976:1–272. Available at: www.goldcopd.com. Accessed November 2003.
- Anthonisen N, Connett J, Friedman B, Glass M, Kilday D P, Mongo T S, Rudolphus A, Williams G W. Design of a clinical trial to test a treatment of the underlying cause of emphysema. Ann NY Acad Sci 1991; 624:31–34. [PUBMED], [INFOTRIEVE], [CSA]
- Pauwels R A, Lofdahl C G, Laitinen L A, Schouten J P, Postma D S, Pride N B, Ohlsson S V. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med 1999; 340:1948–1953. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Vestbo J, Sorensen T, Lange P, Brix A, Torre P, Viskum K. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999; 353(9167):1819–1823. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Burge P S, Calverley P M, Jones P W, Spencer S, Anderson J A. Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study. Thorax 2003; 58(8):654–658. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Group T LHSR. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000; 343(26):1902–1909. [CSA], [CROSSREF]
- Sutherland E R, Allmers H, Ayas N T, Venn A J, Martin R J. Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis. Thorax 2003; 58(11):937–941. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Highland K B, Strange C, Heffner J E. Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med 2003; 138(12):969–973. [PUBMED], [INFOTRIEVE]